CAS | Product Name | MF |
4033-42-5
|
AC-LEU-GLY-OH
|
C10H18N2O4
|
1821769-41-8
|
3-Piperidinamine,N,4-dimethyl-1-(phenylmethyl)-,hydrochloride (1:2),(3S,4R)-
|
C14H23ClN2
|
1012317-71-3
|
N2-(1-Oxohexyl)-L-lysylglycyl-L-histidyl-L-lysinamide acetate (1:)
|
C28H51N9O7
|
936693-22-0
|
2-BroMo-6-fluorophenylacetonitrile, 96%
|
C8H5BrFN
|
1141878-45-6
|
1-(Tetrahydro-2H-pyran-2-yl)-3-(trifluoromethyl)-1H-pyrazol-5-ylboronic acid
|
C9H12BF3N2O3
|
939-89-9
|
cis-2-Phenylcyclopropanecarboxylicacid
|
C10H10O2
|
951661-82-8
|
Tadalafil iMpurity B
|
C20H19N3O3
|
90748-01-9
|
4-HYDROXYMETHYL-PIPERIDINE HCL
|
C6H14ClNO
|
1807988-36-8
|
Rabeprazole Impurity 2
|
C18H19N3O4
|
958001-61-1
|
Desacetyl CefathiaMidine
|
C17H26N4O5S2
|
876717-53-2
|
2-METHYLAMINO-ISONICOTINIC ACID
|
C7H8N2O2
|
1242339-23-6
|
3,4-Difluoro-2-trifluoroMethyl-broMobenzene
|
C7H2BrF5
|
1083325-87-4
|
7-bromo-2-(1-methyl-1H-pyrazol-4-yl)Quinoxaline
|
C12H9BrN4
|
87530-30-1
|
7-Methoxy-9,10-dihydrophenanthrene-2,5-diol
|
C15H14O3
|
20261-24-9
|
3-CHLORO-2-METHYLBIPHENYL
|
C13H11Cl
|
32999-38-5
|
1,2,3,4-Tetrahydro-8-isoquinolinol Hydrochloride
|
C9H12ClNO
|
1203507-02-1
|
(2S,3R)-(+)-3-Isopropyl-2-phenyl-3,4-dihydro-2H-pyrimido[2,1-b][1,3]benzothiazole98+%
|
C19H20N2S
|
1221239-09-3
|
2-Methyl-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-2,3-dihydro-isoindol-1-one
|
C15H20BNO3
|
1708974-11-1
|
2-amino-4-fluoro-cyanopyridine
|
C6H4FN3
|
1691249-44-1
|
(R)-Zanubrutinib
|
C27H29N5O3
|
259674-19-6
|
TRPM8 Antagonist
|
C26H26N2O2
|
5197-58-0
|
Stenbolone
|
C20H30O2
|
23062-51-3
|
Methyl 4-broMobicyclo[2.2.2]octane-1-carboxylate
|
C10H15BrO2
|
146369-65-5
|
H-TYR-TIC-PHE-PHE-OH
|
C37H38N4O6
|
51811-79-1
|
NONOXYNOL-3 PHOSPHATE
|
C17H31O6P
|
524923-88-4
|
JNJ-10229570
|
C22H19N3O2S
|
1395056-42-4
|
Moxifloxacin Impurity 30
|
C21H24FN3O7
|
21651-12-7
|
trans-2,4-Pentadienoicacid
|
C5H6O2
|
885271-73-8
|
TERT-BUTYL 3,7-DIAZABICYCLO[4.2.0]OCTANE-7-CARBOXYLATE
|
C11H20N2O2
|
3418-45-9
|
3-Quinolinol
|
C9H11NO
|
39705-60-7
|
(D-LEU2)-MELANOCYTE-STIMULATING HORMONE-RELEASE INHIBITING FACTOR
|
C13H24N4O3
|
22277-01-6
|
4-Chloro-5-nitro-7H-pyrrolo[2,3-d]pyrimidine
|
C6H3ClN4O2
|
108957-75-1
|
Diethyl 3,5-Dimethoxybenzylphosphonate
|
C13H21O5P
|
464924-27-4
|
H-SER-LEU-LEU-LYS-NH2
|
C21H41N5O6
|
862996-27-8
|
BOC-D-HYP-OTBU
|
C14H25NO5
|
73220-00-5
|
AMbroxol CycloiMine IMpurity
|
C16H22Br2N2O3
|
154170-27-1
|
Pitavastatin
|
C32H36FNO4
|
93830-58-1
|
Pyridine, 4-(diethylboryl)-
|
C9H14BN
|
1198-60-3
|
1,3,5-TRICHLOROBENZENE-D3
|
C6H3Cl3
|
199330-66-0
|
4-AMINOTETRAHYDROPYRAN-4-CARBOXYLIC ACID METHYL ESTER HYDROCHLORIDE
|
C7H14ClNO3
|
91136-43-5
|
3-Hydroxynaphthalene-1-carboxaldehyde
|
C11H8O2
|
438625-61-7
|
MCA-SER-GLU-VAL-ASN-LEU-ASP-ALA-GLU-PHE-ARG-LYS(DNP)-ARG-ARG-NH2
|
C86H125N27O29
|
175676-42-3
|
Trifluoromethyl 4-Methylbenzenesulfonate
|
C8H7F3O3S
|
444910-17-2
|
DICHLORO(DI-Μ-CHLORO)BIS[1,3-BIS(2,6-DI-I-PROPYLPHENYL)IMIDAZOL-2-YLIDENE]DIPALLADIUM (II)
|
2C27H36Cl2N2Pd
|
62008-21-3
|
FUMARIC ACID MONOETHYL ESTER, ZINC SALT
|
C12H14O8Zn
|
106362-32-7
|
ALA-SER-THR-THR-THR-ASN-TYR-THR ACETATE
|
C35H55N9O16
|
54357-18-5
|
1-Bromo-3-methylnaphthalene
|
C11H9Br
|
19437-86-6
|
2-(p-Bromophenyl)-benzo[b]thiophene
|
C14H9BrS
|
5926-35-2
|
BIS(TRIMETHYLSILYL)CHLOROMETHANE
|
C7H19ClSi2
|
1187732-65-5
|
6-Chloro-2-fluoro-3-iodopyridine, 95%
|
C5H2ClFIN
|
25373-21-1
|
ADIPIC-D8 ACID-D2
|
C6D10O4
|
917482-45-2
|
(S)-Citalopram N-Oxide
|
C20H21FN2O2
|
885340-12-5
|
1-[3-(Benzoyloxy)propyl]-2,3-dihydro-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile ethanedioate
|
C34H36F3N3O8
|
188797-80-0
|
Ziprasidone Sulfoxide
|
C21H21ClN4O2S
|
944451-10-9
|
Dimethylammoniumdichlorotri(μ-chloro)bis{(S)-(-)-2,2'-bis[di(3,5-xylyl)phosphino]-1,1'-binaphthyl}diruthenate(II)[NH2Me2][{RuCl((S)-xylbinap)}2 (μ-Cl)3]
|
C106H108Cl5NP4Ru2
|
21829-26-5
|
diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
|
C19H22N2O6
|
147841-68-7
|
HIV (GP120) FRAGMENT (318-327)
|
C48H80N16O12
|
154083-99-5
|
Cabazitaxel Impurity 30
|
C29H36O11
|
199327-59-8
|
Gefitinib Impurity 14
|
C16H20ClN3O3
|
334731-59-8
|
H-ALA-MET-GLN-MET-LEU-LYS-ASP-THR-ILE-OH
|
C44H79N11O14S2
|
43157-23-9
|
(DEAMINO-CYS1,VAL4,D-ARG8)-VASOPRESSIN
|
C46H65N13O11S2
|
1629063-81-5
|
gne-131
|
C23H30N4O3S
|
1082040-95-6
|
1H-Pyrrolo[3,2-c]pyridine, 4-chloro-7-Methyl-
|
C8H7ClN2
|
376355-58-7
|
N N-BIS-[(S)-1-PHENYLETHYL]DIBENZO[D F][
|
C28H26NO2P
|
1004294-77-2
|
2,2,2-Trifluoroacetophenone-4-boronic acid pinacol ester
|
C14H16BF3O3
|
2095840-91-6
|
6,6'-bis(2-methyl-2H-tetrazol-5-yl)-3,3'-bipyridine
|
C14H12N10
|
111011-78-0
|
3-(5,5-diMethyl-2-oxo-1,3,2-dioxaphorinane-2-yl)-4-(3-nitrophenyl)-bu-3-en-2-one
|
C15H18NO6P
|
60006-11-3
|
N,N'-(4-Methyl-1,3-phenylene)bis(1-pyrrolidinecarboxamide)
|
C17H24N4O2
|
30365-63-0
|
(R)-methyl 4-((3R,5R,8S,10S,13R,14S,17R)-3-acetoxy-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate
|
C27H42O4
|
151-00-8
|
isobutyraldehyde oxime
|
C4H9NO
|
74578-10-2
|
4-[(2,6-dichlorophenyl)(4-imino-3,5-dimethylcyclohexa-2,5-dien-1-ylidene)methyl]-2,6-xylidine phosphate (1:1)
|
C23H25Cl2N2O4P
|
96905-67-8
|
2-oxopyrrolidine-3-carboxylic acid
|
C5H7NO3
|
1643354-27-1
|
Rivaroxaban Impurity 61
|
C32H30N4O8
|
1217631-35-0
|
S-2-N-BOC-propane-1,2-diamine hydrochloride
|
C8H19ClN2O2
|
1235445-80-3
|
Indacaterol IMrity
|
C24H28N2O3
|
154348-08-0
|
tert-butyl 1-oxo-2-oxa-8-azaspiro[4.5]decane-8-carboxylate
|
C13H21NO4
|
460081-24-7
|
4-Oxazolecarboxylicacid,2-ethenyl-,ethylester(9CI)
|
C8H9NO3
|
1378388-35-2
|
(3S,5S)-1-(tert-butoxy
carbonyl)-5-(methoxy
carbonyl)pyrrolidine-3
-carboxylic acid
|
C12H19NO6
|
375345-95-2
|
MibaMpator
|
C21H30N2O4S2
|
1303974-47-1
|
1-BOC-3,3-DIFLUORO-4-(HYDROXYMETHYL)PIPERIDINE
|
C11H19F2NO3
|
35891-99-7
|
2-(propylamino)-N-(p-tolyl)propanamide hydrochloride
|
C13H21ClN2O
|
1256966-04-7
|
Tedizolid IMpurity
|
C37H34F2N14O11P2
|
68412-01-1
|
d-Glucitol, reaction products with epichlorohydrin
|
C9H19ClO7
|
219508-19-7
|
3-BROMO-1H-INDOLE-6-CARBOXYLIC ACID
|
C9H6BrNO2
|
120121-07-5
|
5-FLUORO-2-MERCAPTOBENZOIC ACID
|
C7H5FO2S
|
1639429-81-4
|
MATFPFPXUXCLHI-UHFFFAOYSA-N
|
C20H18N2O
|
36261-61-7
|
H-MET-ASN-OH
|
C9H17N3O4S
|
56522-24-8
|
TERT-BUTYLDIMETHYLSILYL CYANIDE
|
C7H15NSi
|
158022-12-9
|
FTASE INHIBITOR III
|
C26H36N4O5S2
|
96383-44-7
|
FMOC-L-SER(BETA-D-GALAC4)-OH
|
C32H35NO14
|
5418-86-0
|
TRIS(METHYLTHIO)METHANE
|
C4H10S3
|
34583-99-8
|
Cyclohexanecarboxylic acid, 3-amino-, trans- (9CI)
|
C7H13NO2
|
87565-98-8
|
3-HYDRAZINOBENZOIC ACID HYDROCHLORIDE
|
C7H9ClN2O2
|
7264-90-6
|
DiMorpholinophosphinyl Chloride
|
C8H16ClN2O3P
|
12014-28-7
|
CADMIUM PHOSPHIDE
|
CdP
|
257639-98-8
|
CP 154526
|
C23H33ClN4
|
25067-34-9
|
Poly(vinyl alcohol-co-ethylene)
|
C4H8O
|
1245943-60-5
|
B-1-dibenzothienylBoronic acid
|
C12H9BO2S
|
1189961-78-1
|
DESISOPROPYLATRAZINE-D5
|
C5H8ClN5
|
122709-21-1
|
(S)-3-BOC-4-(METHOXYMETHYLCARBAMOYL)-2,2-DIMETHYLOXAZOLIDINE
|
C13H24N2O5
|